Advanced search
Publication Cover
Acta Cardiologica Volume 66, 2011 - Issue 4
Submit an article Journal homepage
5
Views
2
CrossRef citations to date
0
Altmetric
Articles

Optimization of biventricular pacing via strain dyssynchrony measurements in a paediatric patient

Clifford L. CuaHeart Center, Nationwide Children’s Hospital, Columbus, Ohio, U.S.A.Correspondence[email protected]
, MD,
Alistair PhillipsHeart Center, Nationwide Children’s Hospital, Columbus, Ohio, U.S.A.
, MD,
Tamara AckleyHeart Center, Nationwide Children’s Hospital, Columbus, Ohio, U.S.A.
, RN,
Pamela S. RoHeart Center, Nationwide Children’s Hospital, Columbus, Ohio, U.S.A.
, MD &
Naomi KerteszHeart Center, Nationwide Children’s Hospital, Columbus, Ohio, U.S.A.
, MD
Pages 527-530 | Received 11 Feb 2011, Accepted 15 Feb 2011, Published online: 23 May 2017

References

  • Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, Abraham WT, Ghio 5, Leclercq C, Bax JJ, Yu CM, Gorcsan J 3rd, St John Sutton M, De Sutter J, Murillo J. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation 2008; 117:2608–16.
  • Cazeau 5, Leclercq C, Lavergne T, Walker 5, Varma C, Linde C, Garrigue 5, Kappenberger L, Haywood GA, Santini M, Bailleul C, Daubert JC; Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001; 344:873–80.
  • Dubin AM, JanousekJ, Rhee E, Strieper MJ, Cecchin F, Law IH, Shannon KM, Temple J, Rosenthal E, Zimmerman FJ, Davis A, Karpawich PP, Al Ahmad A, Vetter VL, Kertesz NJ, Shah M, Snyder C, Stephenson E, Emmel M, Sanatani 5, Kanter R, Batra A, Collins KK. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J Am Coll Cardiol 2005; 46: 2277–83.
  • Rosanio 5, Schwarz ER, Ahmad M, Jammula P. Vitarelli A, Uretsky BF, Birnbaum Y, Ware DL, Atar 5, Saeed M. Benefits, unresolved questions, and technical issues of cardiac resynchronization therapy for heart failure. Am J Cardiol 2005; 96:710–7.
  • Derval N, Steendijk P. Gula U, Deplagne A, Laborderie J, Sacher F, Knecht 5, Wright M, Nault I, Ploux 5, Ritter P. Bordachar P. Lafitte 5, Réant P. Klein GJ, Narayan SM, Garrigue 5, Hocini M, Haissaguerre M, Clementy J, JaIs P. Optimizing hemodynamics in heart failure patients by systematic screening of left ventricular pacing sites: the lateral left ventricular wall and the coronary sinus are rarely the best sites. J Am Coll Cardiol 2010; 55: 566–75.
  • Spragg DD, Dong J, Fetics BJ, Helm R, Marine JE, Cheng A, Henrikson CA, Kass DA, Berger RD. Optimal left ventricular endocardial pacing sites for cardiac resynchronization therapy in patients with ischemic cardiomyopathy. J Am Coll Cardiol 2010; 56: 774–81.
  • Ypenburg C, van Bommel RJ, Delgado V. Mollema SA, Bleeker GB, Boersma E, Schalij MJ, BaxJJ. Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy. J Am Coll Cardiol 2008; 52: 1402–9.
  • Yu CM, Fung WH, Lin H, Zhang Q Sanderson JE, Lau CP. Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol 2003; 91:684–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Novo Nordisk – Driving change to defeat serious chronic diseases.
Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.